Home / Health / Infant Hep B vaccine rules risk missing critical exposures
Infant Hep B vaccine rules risk missing critical exposures
23 Oct
Summary
- New study questions US infant Hepatitis B vaccination policy effectiveness.
- Infected household members, not mothers, pose risk in 58% of cases.
- GLP-1 drug use in pregnancy shows no increased risk for major complications.
New research raises concerns that the United States' revised hepatitis B vaccination guidelines for infants may leave many children vulnerable.
The updated guidelines, part of a broader vaccine policy shift, now recommend birth vaccination only for infants born to mothers with hepatitis B infections or unknown status. This approach may overlook significant exposure risks from other household members.
A study of 158,000 children in northern California revealed that in approximately 58% of cases involving household hepatitis B exposure, the infected individual was not the mother. Hepatitis B can be transmitted through various bodily fluids and surfaces, and chronic infection is common in infants and young children.
Experts emphasize that vaccinating all infants at birth provides protection against both known and unknown transmission sources.
Separately, recent data suggests that pregnant women taking GLP-1 medications for weight loss or diabetes may not need to be overly concerned about potential risks.
While previous advice recommended stopping these drugs before pregnancy, a new analysis of 572 pregnancies found no significant difference in outcomes compared to non-users. This included rates of reaching the second or third trimester, delivery, pregnancy complications, and neonatal health indicators.
Further large-scale studies are needed to definitively establish the safety of semaglutide use during pregnancy.
